Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ibon Martinez"'
Autor:
MARIA AYALA VALVERDE, Jorge Arnold Alvarez, Gustavo Ayares, Francisco Barrera, Daniel Cabrera, Luis Antonio Diaz, Juan Pablo Arab, Ibon Martinez-Arranz, Cristina Alonso, Jesús M. Bañales, Marco Arrese
Publikováno v:
Annals of Hepatology, Vol 29, Iss , Pp 101605- (2024)
Conflict of interest: Yes, Fondecyt # 1241450 Introduction and Objectives: Background: There is limited information on features of lean MASLD patients in Latino subjects. We aimed to analyze the features of MASLD in Chilean patients with normal body
Externí odkaz:
https://doaj.org/article/eaf891990b604b6aaa23afcde128c1f8
Autor:
Laura Palomo, Felix Royo, Justyna Mleczko, Cristina Alonso, Ibon Martinez, Juan M. Falcón-Pérez, A. Castro, Esperanza Gonzalez, Miriam Pérez-Cormenzana
Publikováno v:
European Journal of Pharmaceutical Sciences. 98:51-57
Hepatocytes are involved in the endogenous and drug metabolism; many of the enzymes involved in those processes are incorporated into extracellular vesicles and secreted into the bloodstream. Liver-damaging conditions modify the molecular cargo of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0a9fca469941f83fdfc37c2ef56b144
https://doi.org/10.1016/j.ejps.2016.10.020
https://doi.org/10.1016/j.ejps.2016.10.020
Autor:
Tushar Patel, Adelaida Lacasta, J.P. Jimeno, Esperanza Gonzalez, Gregory J. Gores, Ainhoa Lapitz, Ander Arbelaiz, Frank Lammert, Marco Marzioni, Piotr Milkiewicz, Alvaro Santos-Laso, Mikel Azkargorta, A. Sanchez-Campos, C. Ibarra, Marcin Krawczyk, Jose J.G. Marin, Rocio I.R. Macias, Oihane Erice, Ibon Martinez, Luis Bujanda, Raul Jimenez-Agüero, Felix Elortza, Jesus M. Banales, Maria J. Perugorria, Juan M. Falcón-Pérez
Publikováno v:
Hepatology (Baltimore, Md.). 66(4)
Cholangiocarcinoma (CCA) includes a heterogeneous group of biliary cancers with poor prognosis. Several conditions, such as primary sclerosing cholangitis (PSC), are risk factors. Noninvasive differential diagnosis between intrahepatic CCA and hepato
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ceb7faf48f21d738824625880298aad4
https://pubmed.ncbi.nlm.nih.gov/29311406
https://pubmed.ncbi.nlm.nih.gov/29311406
Autor:
Juan M. Falcón-Pérez, Tushar Patel, Ander Arbelaiz, Gregory J. Gores, Alvaro Santos-Laso, Mikel Azkargorta, J.P. Jimeno, Marco Marzioni, Paula Olaizola, Ibon Martinez, P.Y. Lee, Luis Bujanda, M.J. Perugorria, Esperanza Gonzalez, Adelaida Lacasta, A. Arregi, Rocio I.R. Macias, Jose J.G. Marin, A. Sanchez-Campos, C. Ibarra, L. Izquierdo, Marek Krawczyk, Frank Lammert, O. Erice, Ainhoa Lapitz, Raul Jimenez-Agüero, Felix Elortza, Jesus M. Banales
Publikováno v:
Journal of Hepatology. 66:S207-S208
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9394ea035ee17a0edf8fe6aee39a6892
https://doi.org/10.1016/s0168-8278(17)30712-2
https://doi.org/10.1016/s0168-8278(17)30712-2
Autor:
Javier Michelena, Cristina Alonso, Ibon Martínez-Arranz, José Altamirano, Rebeca Mayo, Pau Sancho-Bru, Ramón Bataller, Pere Ginès, Azucena Castro, Juan Caballería
Publikováno v:
Annals of Hepatology, Vol 18, Iss 1, Pp 144-154 (2019)
Introduction and aims. Alcoholic hepatitis is the most severe manifestation of alcoholic liver disease. Unfortunately, there are still some unresolved issues in the diagnosis and management of this disease, such as the need of histological diagnosis,
Externí odkaz:
https://doaj.org/article/1ffe454fd1394038b448e714c7ecd06f
Autor:
Martine C. Morrison, Lars Verschuren, Kanita Salic, Joanne Verheij, Aswin Menke, Peter Y. Wielinga, Marta Iruarrizaga‐Lejarreta, Laurent Gole, Wei‐Miao Yu, Scott Turner, Martien P.M. Caspers, Ibon Martínez‐Arranz, Elsbet Pieterman, Reinout Stoop, Arianne van Koppen, Anita M. van den Hoek, José M. Mato, Roeland Hanemaaijer, Cristina Alonso, Robert Kleemann
Publikováno v:
Hepatology Communications, Vol 2, Iss 12, Pp 1513-1532 (2018)
Concerns have been raised about whether preclinical models sufficiently mimic molecular disease processes observed in nonalcoholic steatohepatitis (NASH) patients, bringing into question their translational value in studies of therapeutic interventio
Externí odkaz:
https://doaj.org/article/b7dbea0375ad493383bf24d4d1bb040c
Autor:
Rebeca Mayo, Javier Crespo, Ibon Martínez‐Arranz, Jesus M Banales, Mayte Arias, Itziar Mincholé, Rocío Aller de la Fuente, Raúl Jimenez‐Agüero, Cristina Alonso, Daniel A. de Luis, Libor Vitek, Jan Stritesky, Joan Caballería, Manuel Romero‐Gómez, Antonio Martín‐Duce, Jose Maria Mugüerza Huguet, José Ignacio Busteros‐Moraza, Michael O. Idowu, Azucena Castro, M. Luz Martínez‐Chantar, Pablo Ortiz, Radan Bruha, Shelly C. Lu, Pierre Bedossa, Mazen Noureddin, Arun J. Sanyal, José M. Mato
Publikováno v:
Hepatology Communications, Vol 2, Iss 7, Pp 807-820 (2018)
Nonalcoholic fatty liver disease (NAFLD) is the most common type of chronic liver disease worldwide and includes a broad spectrum of histologic phenotypes, ranging from simple hepatic steatosis or nonalcoholic fatty liver (NAFL) to nonalcoholic steat
Externí odkaz:
https://doaj.org/article/3db3e565d647480a965ad1c11a5f01be
Autor:
Ibon Martínez-Arranz, Rebeca Mayo, Miriam Pérez-Cormenzana, Itziar Mincholé, Lorena Salazar, Cristina Alonso, José M. Mato
Publikováno v:
Data in Brief, Vol 3, Iss C, Pp 155-164 (2015)
Metabolomics research has evolved considerably, particularly during the last decade. Over the course of this evolution, the interest in this ‘omic’ discipline is now more evident than ever. However, the future of metabolomics will depend on its c
Externí odkaz:
https://doaj.org/article/f00ccf8d987d4b4e8cc755f21c4b5808